Overview


According to FutureWise analysis the market for Fecal Calprotectin Test in 2023 is US$ 68 Million, and is expected to reach US$ 160 Million by 2031 at a CAGR of 13.1%.

Fecal calprotectin test is a diagnostic test used to measure the level of calprotectin in an individual's stool. Calprotectin is a protein found in white blood cells and is commonly used as a biomarker for inflammation in the intestines, and elevated levels of calprotectin in stool can indicate the presence of inflammation in the gastrointestinal tract. The fecal calprotectin test is used to diagnose and monitor inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis. It is also used to differentiate IBD from other diseases that causes similar symptoms, such as irritable bowel syndrome (IBS).

The test is non-invasive and can be performed easily in a doctor's office or at home with a test kit. The patient collects a small sample of their stool and sends it to a laboratory for analysis. The results of the test are usually available within a few days. The test kit is designed to provide a rapid and accurate result, usually within 15-30 minutes, without requiring laboratory analysis. The test is typically performed using a small stool sample that is collected at home or in a healthcare setting and then processed using the test kit. It is crucial to note that the fecal calprotectin test is not a definitive diagnostic tool for IBD or other digestive disorders, and should be used in combination with other diagnostic tests and clinical evaluation by a healthcare professional.

FutureWise Market Research has published a report that provides an insightful analysis of Fecal Calprotectin Test Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Fecal Calprotectin Test Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Medixbiochemica
  • LifeSpan BioSciences, Inc.
  • RayBiotech, Inc.
  • Eagle Bioscience, Inc.
  • Abbexa Ltd
  • Calpro AS
  • Epitope Diagnostics, Inc.
  • America Diagnosis, Inc.
  • Alpha Laboratories

Recent developments by key players in the Fecal Calprotectin Test Market:

A quick, qualitative in vitro diagnostic test for fecal calprotectin detection, the Solana Fecal Calprotectin Assay from Quidel Corporation was approved by the FDA in March 2021.

Inflammatory bowel disease (IBD) and other gastrointestinal illnesses are becoming more common, which has led to a significant increase in the need for fecal calprotectin tests. The demand for non-invasive diagnostic techniques for IBD that can precisely distinguish between IBD and other gastrointestinal disorders is the key factor driving the market. In addition, the increasing adoption of fecal calprotectin testing in primary care settings and the development of advanced and user-friendly testing kits are expected to further drive market growth.

Furthermore, the high cost of fecal calprotectin testing and limited reimbursement policies may hinder market growth to some extent. In addition, the lack of standardization in fecal calprotectin testing procedures and the need for skilled personnel for testing may also pose a challenge to market growth. The key players are making investments in their R&D for technological advancements, which is expected to propel market expansion and boost the target market's revenue.

By Indication

  • Inflammatory Bowel Disease
  • Colorectal Cancer
  • Celiac Disease
  • Others

By Distribution Channel

  • Hospitals
  • Diagnostic Laboratories
  • Academic & Research Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The market for Fecal calprotectin test is dominated by North America, and this dominance is anticipated to last till the forecast period. The United States has the greatest market share in North America. A factor in the market's expansion is the increased incidence of IBD disorders in the United States, the requirement for early diagnosis, and the introduction of new products by the major market participants. According to a study by Christopher McDowell which was published in the National Library of Medicine, the prevalence of inflammatory bowel disease in North America in May 2022 ranged from 2.2 to 19.2 cases per 100,000 people in a year and from 3.1 to 20.2 cases per 200,000 people in a year for ulcerative colitis. In the US, the prevalence of adult ulcerative colitis and Crohn's disease was 238 per 100,000 and 201 per 100,000, respectively. As a result, it is predicted that the increased incidence of IBD disorders would raise demand for IBD diagnostics, driving market growth.


  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth

  • To provide with an exhaustive analysis on the of Fecal Calprotectin Test Market By Indication, By Distribution channel and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Fecal Calprotectin Test Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Fecal Calprotectin Test Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Fecal Calprotectin Test Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Fecal Calprotectin Test Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Inflammatory Bowel Disease
        2. Colorectal Cancer
        3. Celiac Disease
        4. Others

  • 8.   Fecal Calprotectin Test Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospitals
        2. Diagnostic Laboratories
        3. Academic & Research Institutes

  • 9.   North America Fecal Calprotectin Test Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Fecal Calprotectin Test Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Fecal Calprotectin Test Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Fecal Calprotectin Test Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Medixbiochemica
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. LifeSpan BioSciences, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. RayBiotech, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Eagle Bioscience, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Abbexa Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Calpro A.S.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Epitope Diagnostics, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. America Diagnosis, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Alpha Laboratories
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11